| Active Not Recruiting | ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis Atopic Dermatitis, Atopic, Dermatitis | Phase 2 | 2025-05-30 |
| Completed | Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2024-08-19 |
| Terminated | Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis Psoriatic Arthritis | Phase 2 | 2022-07-12 |
| Completed | Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2022-05-11 |
| Completed | ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumat Rheumatoid Arthritis | Phase 2 | 2022-02-01 |
| Completed | ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) Hidradenitis Suppurativa | Phase 2 | 2021-12-29 |
| Terminated | Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS) Cryopyrin-Associated Periodic Syndrome | Phase 2 | 2020-10-23 |
| Completed | Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2020-09-30 |
| Completed | Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA Rheumatoid Arthritis | Phase 2 | 2020-03-16 |
| Completed | Safety Study of A-101 Topical Solution for the Treatment of Common Warts Common Wart | Phase 3 | 2019-02-07 |
| Terminated | ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Tot Alopecia Areata, Alopecia Universalis, Alopecia Totalis | Phase 2 | 2019-01-15 |
| Completed | Study of A-101 Topical Solution for the Treatment of Common Warts Common Wart | Phase 3 | 2018-09-17 |
| Completed | A Study of A-101 Topical Solution for the Treatment of Common Warts Common Wart | Phase 3 | 2018-09-13 |
| Completed | A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2018-07-10 |
| Completed | ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Alopecia | Phase 2 | 2018-06-11 |
| Completed | Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopeci Alopecia Areata, Alopecia Totalis, Alopecia Universalis | Phase 2 | 2018-04-11 |
| Completed | A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution Androgenetic Alopecia | Phase 2 | 2018-03-22 |
| Completed | An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses Seborrheic Keratosis | Phase 4 | 2018-03-21 |
| Completed | A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo Vitiligo | Phase 2 | 2018-03-19 |
| Completed | Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis Alopecia Universalis (AU), Alopecia Totalis (AT) | Phase 2 | 2017-12-14 |
| Completed | Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea Rosacea | Phase 4 | 2017-12-04 |
| Terminated | A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata Alopecia Areata | Phase 2 | 2017-11-29 |
| Completed | A Phase2 of A-101 Topical Solution in Subjects With Common Warts Common Wart | Phase 2 | 2017-08-01 |
| Completed | A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts Common Wart | Phase 2 | 2017-07-13 |
| Completed | A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra Dermatosis Papulosa Nigra | Phase 2 | 2017-06-26 |
| Completed | A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis Seborrheic Keratosis | Phase 2 | 2017-05-17 |
| Completed | A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. Seborrheic Keratosis | Phase 3 | 2016-01-01 |
| Completed | An Open-Label Safety Study of A-101 Solution Seborrheic Keratosis | Phase 3 | 2016-01-01 |
| Completed | A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis Seborrheic Keratosis | Phase 3 | 2016-01-01 |
| Completed | A Study of A-101 Solution in Subjects With Common Warts. Common Warts | Phase 2 | 2015-12-21 |
| Completed | Study of A-101 for the Treatment of Seborrheic Keratosis Seborrheic Keratosis | Phase 2 | 2014-10-01 |
| Completed | Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis Seborrheic Keratosis | Phase 2 | 2014-06-01 |
| Completed | Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis Seborrheic Keratosis (SK) | Phase 1 / Phase 2 | 2013-10-22 |